Stay updated on Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.

Latest updates to the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange Detected- The changes consist of a new revision entry (Revision: v3.3.3) and removal of the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer; these updates do not alter core trial data, eligibility, locations, or other substantive content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe History page now shows a new revision entry (v3.3.2) added and the previous revision (v3.3.1) removed; no changes to the study data, status, or visible content are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 in the Record History for NCT05162443.SummaryDifference0.1%

- Check49 days agoChange DetectedRemoved the government funding notice about potential updates and operating status from the page header. This change does not affect core study information or navigation.SummaryDifference0.8%

- Check63 days agoChange DetectedThe new screenshot shows a slightly reorganized header and updated Record History layout, with the study title, sponsor, and version dates unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange Detected- Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).SummaryDifference13%

Stay in the know with updates to Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in KRAS G12C+ Solid Tumors Clinical Trial page.